The Impact of Intravenous Iron Supplementation on Hematinic Parameters and Erythropoietin Requirements in Hemodialysis Patients

被引:0
作者
Sepideh Zununi Vahed
Elham Ahmadian
Seyedeh Mina Hejazian
Saba Esmaeili
Farahnoosh Farnood
机构
[1] Tabriz University of Medical Sciences,Kidney Research Center
[2] Tabriz University of Medical Sciences,Student Research Committee
[3] Islamic Azad University of Tabriz Branch,Faculty of Medicine
来源
Advances in Therapy | 2021年 / 38卷
关键词
Hemodialysis; Anemia; Intravenous iron; Erythropoietin; Transferrin saturation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4413 / 4424
页数:11
相关论文
共 86 条
[1]  
Cooper A(2004)Pentoxifylline improves hemoglobin levels in patients with erythropoietin-resistant anemia in renal failure J Am Soc Nephrol 15 1877-1882
[2]  
Mikhail A(2020)Risk factors for anemia in patients with chronic renal failure: a systematic review and meta-analysis Ethiop J Health Sci 30 829-842
[3]  
Lethbridge MW(2010)Anemia in renal disease: diagnosis and management Blood Rev 24 39-47
[4]  
Kemeny DM(2019)Comparing the effects of intravenous and subcutaneous erythropoietin on blood indices in hemodialysis patients Sci Rep 9 1-8
[5]  
Macdougall IC(2014)A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD J Am Soc Nephrol 9 705-712
[6]  
Shiferaw WS(2012)Kidney disease: improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease Kidney Int Supp 2 279-335
[7]  
Akalu TY(2017)Low versus high dose erythropoiesis-stimulating agents in hemodialysis patients with anemia: a randomized clinical trial PLoS One 12 e0172735-268
[8]  
Aynalem YA(2018)Randomized trial comparing proactive, high-dose versus reactive, low-dose intravenous iron supplementation in hemodialysis (PIVOTAL): study design and baseline data Am J Nephrol 48 260-130
[9]  
Lankhorst CE(2017)Serum ferritin variations and mortality in incident hemodialysis patients Am J Nephrol 46 120-35
[10]  
Wish JB(2021)Improving the safety of intravenous iron treatments for patients with chronic kidney disease Expert Opin Drug Saf 20 23-7